Publications

2023

Fahmy LM, Schreidah CM, Lapolla BA, Magro CM, Geskin LJ. VEXAS syndrome presenting as refractory cutaneous Kikuchi disease-like inflammatory pattern responding to tofacitinib. JAAD Case Rep. 2023;38:136-140.
Hacken ET, Sewastianik T, Yin S, Hoffmann GB, Gruber M, Clement K, et al. In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities. Blood Cancer Discov. 2023;4(2):150-169.
Daniels A, Levitan D, Chernichenko N. The Rare Presentation of Multiple Chondroid Syringomas in One Patient: A Case Report. Indian J Otolaryngol Head Neck Surg. 2023;75(2):1250-1252.
Mastini C, Campisi M, Patrucco E, Mura G, Ferreira A, Costa C, et al. Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma. Sci Transl Med. 2023;15(702):eabo3826.
Omar M, Dinalankara W, Mulder L, Coady T, Zanettini C, Imada EL, et al. Using biological constraints to improve prediction in precision oncology. iScience. 2023;26(3):106108.
Kim G, Karadal-Ferrena B, Qin J, Sharma VP, Oktay IS, Lin Y, et al. Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapy. NPJ Breast Cancer. 2023;9(1):52.
McCloskey D, Semeere A, Ayanga R, Laker-Oketta M, Lukande R, Semakadde M, et al. LAMP-enabled diagnosis of Kaposi's sarcoma for sub-Saharan Africa. Sci Adv. 2023;9(2):eadc8913.
Stagg J, Golden E, Wennerberg E, Demaria S. The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Sci Immunol. 2023;8(85):eabq3015.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700